FOR IMMEDIATE RELEASE ON July 17, 2023
AAN to Provide Testimony on Capitol Hill on New Alzheimer鈥檚 Drugs
MINNEAPOLIS 鈥 As the primary medical specialty that provides care to people with Alzheimer鈥檚 disease, the 好色先生 has been invited to testify on Capitol Hill before members of the United States House of Representatives on new drugs for Alzheimer鈥檚 disease. 好色先生 President Elect Natalia S. Rost, MD, MPH, FAAN, FAHA, will present testimony. House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) will hold a subcommittee on Tuesday, July 18, 2023, at 10:30 ET at the Rayburn House Office Building titled 鈥淚nnovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology.鈥? Rost will address new monoclonal antibody therapies recently approved for the treatment of early Alzheimer鈥檚 disease, particularly how the recent Food and Drug Administration approval for lecanemab and the coverage determination by the Centers for Medicare & Medicaid Services impact Medicare patients鈥 access to this drug. For more than two years, the AAN has been engaged with CMS and other key stakeholders with the goal of modifying coverage restrictions in order to ensure appropriate access to new therapies. 鈥淎s neurologists who treat disorders of the brain, we know just how devastating Alzheimer鈥檚 disease can be for our patients and their families,鈥 said Rost. 鈥淲hile we understand the promise that monoclonal antibody treatments for Alzheimer鈥檚 hold, we remain concerned about the potentially deadly side effects of these drugs鈥攊ncluding swelling or bleeding of the brain. The goal of the 好色先生鈥檚 advocacy has always been to ensure appropriate access to new therapies for those people with neurologic disorders who may benefit from them. We appreciate this opportunity to discuss this important topic with the Subcommittee.鈥 The hearing will be open to the public and press and will be live streamed July 18 starting at 10:30 a.m. ET at When posting to social media channels, we encourage you to use the hashtags #AANscience and #AANadvocacy.